CAI CIK: 2019410

Caris Life Sciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25

Assets

(positive)
Change from FY24 to FY25
billions USD
FY24:
0.22
FY25:
1.00
(positive)
Change from FY24 to FY25
billions USD
FY24:
0.13
FY25:
0.13
Total assets
Change from FY24 to FY25
billions USD
FY24:
0.34
FY25:
1.13

Liabilities & Equity

(negative)
Change from FY24 to FY25
billions USD
FY24:
0.17
FY25:
0.13
(negative)
Change from FY24 to FY25
billions USD
FY24:
0.46
FY25:
0.42
(positive)
Change from FY24 to FY25
billions USD
FY24:
−2.50
FY25:
0.58
Total liabilities & equity
billions USD
FY24:
–
FY25:
1.13

All amounts in billions USD Data sources:SEC EDGARTwelve Data